Clinical Trial Update: Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating rituximab-based combination chemotherapy in patients with chronic lymphocytic leukemia that did not respond to fludarabine, including t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hemolytic Anemia
• Chronic Lymphocytic Leukemia
• Richter Transformation

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: German CLL Study Group | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED